JAMA: Getting Pharmacogenomics Into the Clinic

What if there were a way to know if a depressed patient would respond to an antidepressant—before it was prescribed? Or to predict a bleeding event from an antiplatelet therapy? In recent years, advances in genetic testing have made such drug-response predictions possible for patients with certain gene variants.

Great article from JAMA on the continued adoption of pharmacogenomics – full link below:

http://jamanetwork.com/journals/jama/article-abstract/2555987